Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by CravenRaven101on May 25, 2012 10:48am
246 Views
Post# 19946023

RE: Monetize and The Act of War

RE: Monetize and The Act of War

I do not nor have I ever taken a postion on regulators, your assertion that I am a "professional investor" could not be further from the truth... MY position is clear... and my disagreement with Germini even more clear... I hold that the price of a pharmaceutical developer with a single product in the development approval stage ought to be priced accordingly... and that should said product achieve FDA approval, the share price ought rise......no different than a mining company with an inferred mineral resource and plans to build a mine... OR an OIl and Gas company that knows there's oil "down there" with no money to bring it to the surface...

 

On a personal note... it should be stated that Germini LOST his previous alias by virtue of following me from one company board to the next in an effort to "cyber bully" me...and to wantonly promote ONC on those other company boards... Moral high ground indeed... and once again here he is... another bullying effort... trying to censor his critics with veiled threats... I welcome his scrutiny... I stand in the light and have only ever posted under a single name...I neither promote, or "bash" I merely offer a counterpoint to what I believe are unbalanced views and opinions... and once he has completed his "efforts to draw back the "veil" lawmakers and regulators will see HIM for what he is...

 

as always, the opinions expressed here are strictly my own, do your DD... GLTA

Bullboard Posts